[CIS-PAGID] Chr 22q11.2 duplication

Verbsky, James jverbsky at mcw.edu
Tue Feb 14 23:38:49 EST 2012


We have a similar patient here with no evidence of immune deficiency.

Sorry for the brevity. Sent from my iPhone. James

On Feb 14, 2012, at 8:39 PM, "Vivian Hernandez-trujillo" <drbibi at pol.net> wrote:


> Dear Joe-

>

> We have the same experience in Miami.

>

> Viv

> ----- Original Message -----

> From: "Joseph Church" <JChurch at chla.usc.edu>

> To: pagid at list.clinimmsoc.org

> Sent: Tuesday, February 14, 2012 8:03:13 PM GMT -05:00 US/Canada Eastern

> Subject: Re: [CIS-PAGID] Chr 22q11.2 duplication

>

>

>

>

> Thanks, Kate. Exactly what I needed. JC

>

>

>

>

>

> From: pagid-bounces at list.clinimmsoc.org [mailto:pagid-bounces at list.clinimmsoc.org] On Behalf Of Kate Sullivan

> Sent: Tuesday, February 14, 2012 4:52 PM

> To: pagid at list.clinimmsoc.org

> Subject: Re: [CIS-PAGID] Chr 22q11.2 duplication

>

>

>

> We have found a number here and while they have many featured in common with the deletions, they have not (so far) had an immune deficiency.

>

>

>

>

>

> Kate

>

>

>

> Kate Sullivan, MD PhD

> Professor of Pediatrics

> ARC 1216 Immunology CHOP

> 3615 Civic Center Blvd.

> Philadelphia, PA 19104

> (p) 215-590-1697

>

>

> (f) 267-426-0363

>

>

>

>

>

> On Feb 14, 2012, at 6:09 PM, Church, Joseph wrote:

>

>

>

>

>

>

>

> Colleagues:

>

>

>

>

>

> I have been asked to see a 1yo with congenital anomalies, chronic lung disease, PDA ligation and coarc repair, and acute pneumonia. The patient phenotypically looks like a DiGeorge patient. She has chr 22q11.2 duplication .

>

>

>

>

>

> Do patients with 22q.11.2 duplication have immunodeficiency?

>

>

>

>

>

> Thank you.

>

>

>

>

>

> Joe Church

>

>

> Children's Hospital Los Angeles

>

>

>

>

>

>

>

>

> ---------------------------------------------------------------------

> CONFIDENTIALITY NOTICE: This e-mail message, including any attachments,

> is for the sole use of the intended recipient(s) and may contain confidential

> or legally privileged information. Any unauthorized review, use, disclosure

> or distribution is prohibited. If you are not the intended recipient, please

> contact the sender by reply e-mail and destroy all copies of this original message.

> ---------------------------------------------------------------------

>

>

>

>

> ---------------------------------------------------------------------

> CONFIDENTIALITY NOTICE: This e-mail message, including any attachments,

> is for the sole use of the intended recipient(s) and may contain confidential

> or legally privileged information. Any unauthorized review, use, disclosure

> or distribution is prohibited. If you are not the intended recipient, please

> contact the sender by reply e-mail and destroy all copies of this original message.

> ---------------------------------------------------------------------

>



More information about the PAGID mailing list